<label id="zosxy"><s id="zosxy"><pre id="zosxy"></pre></s></label><label id="zosxy"><s id="zosxy"><wbr id="zosxy"></wbr></s></label>
<cite id="zosxy"><s id="zosxy"></s></cite>
        <cite id="zosxy"><del id="zosxy"></del></cite>

            ABOUT US
            Pioneering Global Regenerative Science & Technology
            Essex Bio-Technology is a bio-pharmaceutical company that develops, manufactures and commercialises genetically engineered therapeutic rb-bFGF (FGF-2), having six commercialized biologics marketed in China since 1998. The products of the Company are principally prescribed for the treatment of wounds healing and diseases in Ophthalmology & Dermatology.
            More
            1
            Pioneer & Leader in Growth Factor
            1st global rb-bFGF drug — Beifuji

            1st global rb-bFGF eye drops — Beifushu
            2
            Solid APIs & R&D Capability
            Various proprietary APIs

            Diversified pipeline primarily in ophthalmology

            Honoured with the second prize of National Scientific and Technology Progress Award in 2004 and 2018
            3
            Entrenched Market Foothold
            9760 hospitals under sales & distribution coverage in China

            Market leader of growth factor drugs in Ophthalmology and Dermatology arena
            R&D
            Tomorrow's today
            4 In-house R&D platforms:

            · Growth Factor
            · Antibody
            · Drug Formulation
            · Blow-Fill-Seal (BFS)

            Leveraging on its in-house R&D platform,the Company maintains a pipeline of projects in various clinical stages, covering a wide range of fields of indication
            More
            R&D
            Tomorrow's today
            4 In-house R&D platforms:

            · Growth Factor
            · Antibody
            · Drug Formulation
            · Blow-Fill-Seal (BFS)

            Leveraging on its in-house R&D platform,the Company maintains a pipeline of projects in various clinical stages, covering a wide range of fields of indication
            More
            PRODUCTS
            Harnessing Innovations to Deliver Unmet Drugs for Blessing of People at Large
            We are dedicated to deliver products in Ophthalmology and Surgical arena, including three flagship product series: Beifushu, Beifuji and Beifuxin, which are prescribed for the treatment of wounds healing and diseases in Ophthalmology and Dermatology.
            Information is solely for medical professionals.
            Beifushu Eye Drops
            Beifushu is a national  category I new drug developed and manufactured by Zhuhai Essex Bio-Pharmaceutical Co.,Ltd., the first domestic eye drops that can stimulate corneal reparation and improve healing quality of cornea.
            More
            Beifushu Eye Gel
            Beifushu eye gel is a genetically engineered new drug developed and manufactured by Zhuhai Essex Bio-Pharmaceutical Co., Ltd.. Carbomer -a new generation of artificial tears, as a new matrix of the eye gel, can give patients a sustainable relief.

            With the effect of bFGF, Beifushu eye gel can stimulate corneal reparation and improve healing quality of cornea, keeping cornea in homeostasis.
            More
            Unit-dose Beifushu Eye Drops
            Single-dose Befushu eye drops is a genetically engineered new drug developed and manufactured by Zhuhai Essex Bio-Pharmaceutical Co., Ltd.. As the third generation of Beifushu Series, it is a preservative-free formulation potentially delivering best treatment outcomes to patients.
            More
            Beifuji Spray
            Beifuji  is a national  category I new drug developed and manufactured by Zhuhai Essex Bio-Pharmaceutical Co.,Ltd..

            The API of Beifuji Spray is recombinant bovine basic fibroblast growth factor (rb-bFGF) – a multifunctional growth factor with a wide range of bioactivities, which can stimulate the proliferation and differentiation of cells in the process of wound healing and further improve the healing quality.
            More
            Beifuji Lyophilized Powder
            Beifuji Lyophilized Powder is a national  category I new drug developed and manufactured by Zhuhai Essex Bio-Pharmaceutical Co.,Ltd..

            The API of  Beifuji Lyophilized Powder is recombinant bovine basic fibroblast growth factor (rb-bFGF) – a multifunctional growth factor with a wide range of bioactivities, which can stimulate the proliferation and differentiation of cells in the process of wound healing and further improve the healing quality.
            More
            Beifuxin Gel
            Beifuxin gel is a genetically engineered new drug developed and manufactured by Zhuhai Essex Bio-Pharmaceutical Co., Ltd..

            The API of Beifuxin is recombinant bovine basic fibroblast growth factor (rb-bFGF) - a multifunctional growth factor with a wide range of bioactivity, which can stimulate the proliferation and differentiation of cells involved in wound healing
            More
            NEWS
            This website uses cookies to improve your overall experience. With your continued use, you are agreeing to accept our use of cookies.